Jefferies Financial Group’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-35,000
Closed -$394K – 1727
2024
Q4
$394K Buy
35,000
+10,000
+40% +$176K ﹤0.01% 1181
2024
Q3
$707K Buy
25,000
+19,100
+324% +$492K 0.01% 881
2024
Q2
$113K Hold
5,900
– – ﹤0.01% 1278
2024
Q1
$193K Sell
5,900
-18,400
-76% -$587K ﹤0.01% 1351
2023
Q4
$803K Buy
+24,300
New +$688K 0.01% 1050

Other funds holding EVH

Jefferies Financial Group's EVH Position: Q2 2026 in Review

Jefferies Financial Group held its Evolent Health (EVH) position steady in Q2 2026 at 291,600 shares worth $1.58M. The position accounts for 0.01% of the portfolio, ranked #778.

Jefferies Financial Group first reported a position in EVH in Q4 2022 and has held it in 15 quarters since. The position peaked at $5.4M in Q2 2025. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Jefferies Financial Group held 291,600 shares of Evolent Health worth $1.58M as of Q2 2026.
  • Jefferies Financial Group left its Evolent Health share count unchanged in Q2 2026.
  • Evolent Health made up 0.01% of Jefferies Financial Group's portfolio in Q2 2026, its #778 holding.
  • Jefferies Financial Group first reported a position in Evolent Health in Q4 2022 and has held it in 15 quarters since.
  • Jefferies Financial Group's Evolent Health position peaked at $5.4M in Q2 2025.
  • 198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.